The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Part of paid clinical trials in Newport Beach, California.
- Sponsor
- Aldeyra Therapeutics, Inc.
- Study ID
- NCT03879863
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Reproxalap Ophthalmic Solution (0.25%) QID — DRUGReproxalap Ophthalmic Solution (0.25%) administered QID for twelve weeks
- Vehicle Ophthalmic Solution QID — DRUGVehicle Ophthalmic Solution administered QID for twelve weeks
- Reproxalap Ophthalmic Solution (0.25%) QID to BID — DRUGReproxalap Ophthalmic Solution (0.25%) administered QID for four weeks, followed by BID administration for eight weeks
- Vehicle Ophthalmic Solution QID to BID — DRUGVehicle Ophthalmic Solution administered QID for four weeks, followed by BID administration for eight weeks
Study Details
The RENEW Trial is a Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap 0.25% Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
Key Dates
- Start date
- Apr 16, 2019
- Status verified
- Jan 2025
- Primary completion
- Oct 4, 2019
- Completion
- Oct 4, 2019
Study Design
- Enrollment
- 422 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Reproxalap Ophthalmic Solution (0.25%) QID
- Placebo Comparator: Vehicle Ophthalmic Solution QID
- Experimental: Reproxalap Ophthalmic Solution (0.25%) QID to BID
- Placebo Comparator: Vehicle Ophthalmic Solution QID to BID
Primary Outcome Measure
Subject-reported Ocular Dryness Score (0 - 100 Visual Analogue Scale (VAS)) [ Time Frame: The efficacy assessment period (Day 1 through 85) was assessed at Weeks 1, 2, 4, 6, 8, 10, and 12; baseline was Day 1. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Eye Research Foundation | Newport Beach | California | 92663 | - |
Find similar trials in Newport Beach, CA
By research site
Related Studies
- An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyePHASE2 · Recruiting · Vanda Pharmaceuticals · Newport Beach, California
- Vevye + Flarex Combination Therapy for Dry EyePHASE4 · Enrolling By Invitation · Canyon City Eyecare · Azusa, California
- Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye TreatmentPHASE4 · Recruiting · University of California, Berkeley · Berkeley, California
- Penn SICCA Follow-up StudyNot Yet Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania